{"id":"W4281633450","doi":"10.33380/2305-2066-2022-11-2-180-186","title":"Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Antibody; Medicine; Virology; Immunoglobulin G; Drug; Polyclonal antibodies; Antiviral drug; Coronavirus disease 2019 (COVID-19); Immunology; Pharmacology; Infectious disease (medical specialty); Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169448,0.001143316,0.0009246203,0.0002899689,0.000265418,0.0008000562,0.0005776145,0.000893015,0.002712304],"category_scores_gemma":[0.0005750021,0.0004544004,0.0007131787,0.0002207703,0.0005455192,0.0004277327,0.0001727133,0.002056263,0.0007797297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008110316,"about_ca_system_score_gemma":0.001531349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006678107,"about_ca_topic_score_gemma":0.0007460094,"domain_scores_codex":[0.9997007,0.0001045987,0.000008957706,0.00007526299,0.00004070345,0.00006977371],"domain_scores_gemma":[0.9996738,0.00004101964,0.0000648951,0.00004191901,0.00004929187,0.0001289704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3760144,0.1068903,0.007492187,0.000958881,0.001259075,0.0004042512,0.0003890587,0.006084933,0.3660979,0.001534048,0.01210443,0.1207705],"study_design_scores_gemma":[0.1059623,0.7547513,0.0162325,0.0000682738,0.0008259992,0.0009650667,0.0001012088,0.004689618,0.08683127,0.0006174094,0.02888612,0.00006899747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816371,0.003096042,0.004505148,0.0004472807,0.0003207812,0.003657399,0.002324681,0.0003161072,0.003695475],"genre_scores_gemma":[0.9796593,0.002002128,0.003144627,0.0009955578,0.0001752213,0.002545551,0.003424088,0.00009962506,0.007953939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002712304,"threshold_uncertainty_score":0.009073555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07213643085207633,"score_gpt":0.3924006549297945,"score_spread":0.3202642240777182,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}